CAR-T cells and endogenous CD8+ T cells have similar gene expression and chromatin accessibility, so CAR-T cells will also be stimulated by sustained antigens during anti-tumor immunity, driving CAR-T cell exhaustion (189). The gene discussed is CD8A; the disease is neoplasm.